Thompson Peter A.

Insider Buys Quantity –
29
2024-01-23PurchaseEdgewise Therapeutics, Inc.
EWTX
454,545
0.5075%
$11.00$5M+11.23%
2022-09-16PurchaseEdgewise Therapeutics, Inc.
EWTX
484,496
1.0067%
$10.32$5M-6.89%
2022-05-18PurchaseEdgewise Therapeutics, Inc.
EWTX
276,000
0.5524%
$7.21$1.99M+30.03%
2021-12-29SaleJanux Therapeutics, Inc.
JANX
director
40,400
0.1004%
$20.30$820,120-30.21%
2021-12-21SaleJanux Therapeutics, Inc.
JANX
director
119,400
0.2901%
$19.00$2.27M-26.45%
2021-12-16SaleJanux Therapeutics, Inc.
JANX
director
393,300
0.9489%
$19.07$7.5M-26.9%
2021-09-20SaleCorvus Pharmaceuticals, Inc.
CRVS
1.11M
2.4922%
$6.09$6.76M-73.58%
2021-06-15PurchaseJanux Therapeutics, Inc.
JANX
director
705,853
6.4368%
$17.00$12M+1.61%
2021-03-30PurchaseEdgewise Therapeutics, Inc.
EWTX
718,750
0.7478%
$16.00$11.5M-42.5%
2021-02-17PurchaseCorvus Pharmaceuticals, Inc.
CRVS
1.29M
3.6216%
$3.50$4.5M-23.75%
2020-09-25PurchasePMV Pharmaceuticals, Inc.
PMVP
950,000
7.5696%
$18.00$17.1M-7.38%
2019-08-06PurchaseCorvus Pharmaceuticals, Inc.
CRVS
142,656
0.4786%
$3.51$500,723-1.4%
2019-07-01PurchaseCorvus Pharmaceuticals, Inc.
CRVS
59,243
0.1899%
$3.91$231,640-15.42%
2019-06-28PurchaseCorvus Pharmaceuticals, Inc.
CRVS
565,178
1.918%
$3.72$2.1M-5.88%
2019-06-27PurchaseCorvus Pharmaceuticals, Inc.
CRVS
32,923
0.1107%
$3.34$109,963+3.98%
2018-06-06SaleAdaptimmune Therapeutics plc
ADAP
director
3,200
0.0036%
$13.49$43,168-55.42%
2018-06-04SaleAdaptimmune Therapeutics plc
ADAP
director
34,200
0.0382%
$13.57$464,094-55.39%
2018-06-01SaleAdaptimmune Therapeutics plc
ADAP
director
100,000
0.1066%
$13.49$1.35M-57.22%
2018-05-30SaleAdaptimmune Therapeutics plc
ADAP
director
242,000
0.2641%
$13.52$3.27M-55.89%
2018-05-14SaleAdaptimmune Therapeutics plc
ADAP
director
20,600
0.0231%
$13.50$278,100-51.61%
Stocks ScreenerTop-50 StocksInsiders ScreenerList of All Stocks
About Prismo.proPrivacy PolicyTerms of ServiceContact Us